BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24328844)

  • 1. The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
    Yekaninejad MS; Ahmadzadeh A; Mosavi SH; Saffari M; Pakpour AH; Tolooei F; Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):147-56. PubMed ID: 24328844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
    Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
    Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
    Zhang L; Su YJ; Chen JY; Liao ZC; Luo ZQ; Xie SM; Zhang J; Lin YS; Guo H; Sun WL; Pekbay B; Miller AR; Luo L; Rui YH; Li MH; Wang CL
    Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
    Püsküllüoğlu M; Tomaszewski KA; Bottomley A; Holden L; Tomaszewska IM; Głowacki R; Bereza K; Golec EB; Chow E; Krzemieniecki K
    Qual Life Res; 2014 Mar; 23(2):527-32. PubMed ID: 23912854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY; Pakpour AH
    Asian Pac J Cancer Prev; 2016; 17(3):1405-10. PubMed ID: 27039780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
    Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
    Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
    Yeh DC; Chen DR; Chao TY; Chen SC; Wang HC; Rau KM; Feng YH; Chang YC; Lee KD; Ou-Yang F; Kuo WH; Chang KJ; Lin YC; Tseng LM; Hou MF
    In Vivo; 2014; 28(5):1001-4. PubMed ID: 25189922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation into Portuguese, cross-cultural adaptation and validation of "The European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-Bone Metastases-22".
    Miki-Rosário N; Garcia Filho RJ; Garcia JG; Dini GM; Bottomley A; Chow E; Sabino Neto M
    Ann Palliat Med; 2016 Jul; 5(3):190-5. PubMed ID: 27334351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17.
    Yekaninejad MS; Pakpour AH; Tadakamadla J; Kumar S; Mosavi SH; Fridlund B; Bottomley A; Aaronson NK
    Support Care Cancer; 2015 May; 23(5):1215-24. PubMed ID: 25312650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
    Zeng L; Chow E; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bedard G; Bottomley A
    Support Care Cancer; 2012 Dec; 20(12):3307-13. PubMed ID: 22562607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H; Rajapaksa LC; Greimel ER
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.